15 month delay in diagnosis of anal cancer
Arti Shah was instructed by AB to pursue a claim against the Royal London Hospital in relation to a 14 month delay in diagnosis of squamous cell carcinoma following which she had to undergo chemo-radiotherapy.
AB had undergone an examination under anaesthetic (EUA) and biopsies identified grade 3 anal intra-epithelial neoplasia (AIN), an abnormality of skin cells which are a risk factor for anal cancer. She was referred to the care of the colorectal team at the Royal London Hospital.
Following examination, it was decided she should be kept under surveillance. She had 6 monthly follow up appointments. In early 2011 she was advised that repeat biopsies needed to be performed to exclude any changes to the cells from the previous year. A pre-operative assessment was carried out, but the procedure itself was cancelled.
AB eventually underwent an EUA with biopsies in June 2011 which was negligently performed. A series of 8-12 biopsies should have been taken and sent for histo-pathological examination. If this had been done, it would have identified an extensive area of abnormal cells in the anal canal requiring treatment.
Instead, she remained under review and further investigations were not performed.
By mid-2012, AB had significant concerns. In October 2012 she sought a second opinion from a colorectal surgeon on a private basis. He immediately performed a rectal examination which identified a suspicious lesion. She was referred for an urgent EUA and histology confirmed squamous cell carcinoma. She subsequently underwent 5.5 weeks of chemo-radiotherapy.
We sent a detailed letter of claim after obtaining independent expert evidence from a colorectal surgeon. We alleged that the biopsies taken in June 2011 had been performed negligently. If the correct number had been taken, they would have identified abnormal cells. On the balance of probabilities, treatment in June 2011 would have either prevented the cancer in 2012 or would have led to further biopsies which would have prevented/identified the cancer in 2012. It took a second opinion, which the Claimant obtained on a private basis at her own cost, before she was diagnosed and provided with suitable treatment.
The Defendant admitted that there had been a delay in diagnosis of over 1 year, which had caused AB unnecessary pain and suffering.
Settlement negotiations were entered into, and the case settled before proceedings had to be issued.
At the end of the case, AB's daughter commented:
"I would like to thank you for your support, commitment and professionalism, and for keeping me informed and taking the time to explain the process of the legal proceedings and for a successful completion. I would definitely recommend Arti to family and friends."
- You can speak to our medical negligence solicitors on freephone 0800 358 3848
- e-Mail us at firstname.lastname@example.org
- Complete our short enquiry form
Contact us on freephone 0800 358 3848
Or start your claim online.
"The group is praised for its commitment to 'demystifying the legal process' while this is a firm for which the client has always been a priority"
Fieldfisher has successfully been recognised as an "Occupation and Asbestos Disease Specialists" Fieldfisher are now recognised as assessors
Charities we support
Fieldfisher boosts its leading medical negligence team with partner Jenny Urwin joining in March
Leading medical negligence lawyers Fieldfisher has hired Jenny Urwin, Slater and Gordon Lawyers' Manchester head of clinical negligence.
Substantial six-figure damages for permanent bilateral vocal cord palsy injury at Hillingdon Hospital
Arti Shah has successfully concluded a permanent bilateral vocal cord palsy case for a substantial sum against Hillingdon Hospital.
Sepsis: lack of funding for vital health services must not deter parents from seeking help
Sepsis hit the headlines again last week following the tragic death of 18-year-old Melissa Whiteley.
A Face in the Crowd: Maxillofacial Trauma Conference
Fieldfisher is pleased to be running a conference in London on the 15th March 2018 to discuss different aspects of maxillofacial injuries.